Yuji Matsuzawa
Osaka, 5300005, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
Association of Serum Soluble T-cadherin Levels with Metabolic Syndrome in Japanese Participants Undergoing Health Checkups.
Journal: Journal of atherosclerosis and thrombosis
Published: November 03, 2025
A Man with Primary Hyperchylomicronemia with Triglyceride Levels Exceeding 11,000 mg/dL Was Well Controlled by Pemafibrate Combined with Dietary Therapy.
Journal: Internal medicine (Tokyo, Japan)
Published: July 24, 2024
Myocardial fat accumulation is associated with cardiac dysfunction in patients with type 2 diabetes, especially in elderly or female patients: a retrospective observational study.
Journal: Cardiovascular diabetology
Published: November 29, 2022
The Combination of High Levels of Adiponectin and Insulin Resistance Are Affected by Aging in Non-Obese Old Peoples.
Journal: Frontiers in endocrinology
Published: October 30, 2021
Integrated Analysis of Two Probucol Trials for the Secondary Prevention of Atherosclerotic Cardiovascular Events: PROSPECTIVE and IMPACT.
Journal: Journal of atherosclerosis and thrombosis
Published: April 19, 2021
Adiposity measures and mortality in an Asian population.
Journal: Nature reviews. Endocrinology
Published: November 18, 2020
New Horizons for Probucol, an Old, Mysterious Drug.
Journal: Journal of atherosclerosis and thrombosis
Published: June 09, 2020
Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Coronary Heart Disease (PROSPECTIVE).
Journal: Journal of atherosclerosis and thrombosis
Published: April 28, 2020
Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases.
Journal: Current atherosclerosis reports
Published: January 25, 2020
Last Updated: 09/26/2026